Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Sun Pharmaceutical Industries Ltd is quoting at Rs 1914.2, up 0.07% on the day as on 12:44 IST on the NSE. The stock is up 14.45% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% ...

Bernstein initiates positive coverage on India Healthcare. Indian biopharma poised for transformative growth. Zydus, Lupin, ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Vertex said the acquisition will strengthen its pipeline and could eventually add around $5 billion in annual revenue. ・Crinetics focuses on developing treatments for endocrine diseases. ・Vertex will ...

Two Tennessee National Guard members assigned to a crime-fighting patrol in Memphis fatally shot a man Sunday who turned ...

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Those who allege fraud must prove it — affirmatively, and to a standard higher than the ordinary balance of probabilities. The petitioners, ...

Delhi High Court restrained Finecure Pharmaceuticals from manufacturing drugs similar to Sun Pharma's 'Pantocid,' allowing limited time to sell existing 'Pantopacid' stock.

Pharma stocks are grabbing attention due to strong healthcare demand, rising global medicine need and increasing exports.

Join us on the Sun Pharma Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock.

The debut of Vaibhav Sooryavanshi is a highly discussed chapter in Indian cricket now, since he got his maiden call for the Ireland and England series.